Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-β

Autoimmunity

Volumn 36, Issue 5, 2003, Pages 291-305

  Mix, Eilhard ^a   Stefan, Katja ^a   Höppner, Jacqueline ^a   Klauer, Thomas ^a   Zettl, Uwe K ^a   Strauss, Ulf ^a   Meyer Rienecker, Hans J ^a   Rolfs, Arndt ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Apoptosis; Flow cytometry; Interferon ; Lymphocyte subpopulations; Multiple sclerosis; Oxidative burst

Indexed keywords

INTERFERON BETA SERINE; INTERLEUKIN 2 RECEPTOR; PLACEBO;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; FETUS; FLOW CYTOMETRY; GRANULOCYTE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE COUNT; LONG TERM CARE; MALE; MONOCYTE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PHASE 3 CLINICAL TRIAL; POLYMORPHONUCLEAR CELL; RELAPSE; REMISSION; RESPIRATORY BURST; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBODIES, MONOCLONAL; APOPTOSIS; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; IN SITU NICK-END LABELING; INTERFERON-BETA; LEUKOCYTES; LYMPHOCYTE SUBSETS; MALE; MONOCYTES; MULTIPLE SCLEROSIS; RESPIRATORY BURST; T-LYMPHOCYTES;

EID: 0041562496     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693031000152697     Document Type: Article

References (63)

1. Adorini, L. (2001) "Selective immunointervention in autoimmune diseases: Lessons from multiple sclerosis", J. Chemother. 13, 219-234.
2. Jacobs, L.D., Beck, R.W., Simon, J.H., Kinkel, R.P., Brownscheidle, C.M., Murray, T.J., Simonian, N.A., Slasor, P.J. and Sandrock, A.W. CHAMPS Study Group. (2000) "Intramuscular interferon β-1a therapy initiated during a first demyelinating event in multiple sclerosis", N. Engl. J. Med. 343, 898-904.
3. Durelli, L., Ferrero, B., Grezzi, A., Montanari, E., Zaffaroni, M., Bergui, M., Verdun, E. and Barbero, P. The INCOMIN Trial Study Group. (2001) "The independent comparison of interferon (INCOMIN) trial: A multicenter randomized trial comparing clinical and MRI efficacy of IFNβ-1a and α-1b in multiple sclerosis. INCOMIN Study Group (Abstract)", Neurology 56(Suppl. 3), A148.
4. Brod, S.A., Nelson, L.D., Khan, M. and Wolinsky, J.S. (1997) "IFN-β 1b treatment of relapsing multiple sclerosis has no effect on CD3-induced inflammatory of counterregulatory anti-inflammatory cytokine secretion ex vivo after nine months", Int. J. Neurosci. 90, 135-144.
5. Özenci, V., Kouwenhoven, M., Teleshova N., Pashenkov, M., Fredrikson, S. and Link, H. (2000) "Multiple sclerosis: Pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-β, J. Neuroimmunol. 108, 236-243.
6. Karp, C.L., Van Boxel-Dezaire, A.H.H., Byrnes, A.A. and Nagelkerken, L. (2001) "Interferon-β in multiple sclerosis: Altering the balance of interleukin-12 and interleukin-10?", Curr. Opin. Neurol. 14, 361-368.
7. + B cells in active multiple sclerosis and reversal by interferon β-1b therapy", J. Clin. Investig. 99, 2664-2671.
8. Yong, V.W., Chabot, S., Stüve, O. and Williams, G. (1998) "Interferon β in the treatment of multiple sclerosis. Mechanisms of action", Neurology 51, 682-689.
9. Soilu-Hänninen M., Salmi, A. and Salonen, R. (1995) "Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes". J. Neuroimmunol. 60, 99-106.
10. Jiang, H., Williams G.J. and Dhib-Jalbut, S. (1997) "The effect of interferon β-1b on cytokine-induced adhesion molecule expression", Neurochem. Int. 30, 449-453.
11. Nguyen, L.T., Ramanathan, M., Munschauer, F., Brownscheidle, C., Krantz, S., Umhauer, M., Miller, C., DeNardin, E. and Jacobs, L.D. (1999) "Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients", Clin. Immmunol. 19, 179-185.
12. Kallmann, B.A., Hummel, V., Lindenlaub, T., Ruprecht, K., Toyka, K.V. and Rieckmann, P. (2000) "Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1", Brain 123, 687-697.
13. Liu, Z., Pelfrey, C.M., Cotleur, A., Lee, J.C. and Rudick, R.A. (2001) "Immunomodulatory effects of interferon β-1a in multiple sclerosis", J. Neuroimmunol. 112, 153-162.
14. Wandinger, K.P., Stürzebecher, C.S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L.M., McFarland, H.F. and Martin, R. (2001) "Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes", Ann. Neurol. 50, 349-357.
15. Sørensen, T.L., Roed, H. and Sellebjerg, F. (2002) "Chemokine receptor expression on B cells and effect of interferon-β in multiple sclerosis", J. Neuroimmunol. 122, 125-131.
16. Stüve, O., Dooley, N.P., Uhm, J.H., Antel, J.P., Francis, G.S., Williams, G. and Yong, V.W. (1996) "Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9", Ann. Neurol. 40, 853-863.
17. Zettl, U.K., Mix, E., Zielasek, J., Stangel, M., Hartung, H.-P. and Gold, R. (1997) "Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro", Cell Immunol. 178, 1-8.
18. Hua, L.L., Liu, J.S., Brosnan, C.F. and Lee, S.C. (1998) "Selective inhibition of human glial inducible nitric oxide synthase by interferon-β: Implications for multiple sclerosis", Ann. Neurol. 43, 384-387.
19. Alcazar, A., Regidor, I., Masjuan, J., Salinas, M. and Alvarez-Cermeno, J.C. (1998) "Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons", Neurosci. Lett. 16, 75-78.
20. Rep, M.H., Schrijver, H.M., Van Lopik, T., Hintzen, R.Q., Roos, M.T., Ader, H.J., Polman, C.H. and Van Lier, R.A. (1999) "Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-β producing T cells in MS patients", J. Neuroimmunol. 96, 92-100.
21. -T cells in neuroimmunological diseases", J. Neuroimmunol. 92, 123-132.
22. + oligodendrocytes in multiple sclerosis", Proc. Natl Acad. Sci. USA 88, 6452-6456.
23. + T cells in inflammatory diseases of the nervous system", J. Neuroimmunol. 49, 59-66.
24. Scott, T.F., McKolanis, J., Rothfus, W. and Cottington, E. (1994) "Lymphocyte subsets in relapsing-remitting multiple sclerosis: A longitudinal study of B lymphocytes and T lymphocytes", Neurol. Res. 16, 385-388.
25. Hohlfeld, R. and Wekerle, H. (2001) "Immunological update on multiple sclerosis", Curr. Opin. Neurol. 14, 299-304.
26. Gran, B., Hemmer, B., Vergelli, M., McFarland, H.F. and Martin, R. (1999) "Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity", Ann. Neurol. 45, 559-567.
27. Wucherpfennig, K.W. (2001) "Structural basis of molecular mimicry", J. Autoimmun. 16, 293-302.
28. Arnason, B.G.W. (1996) "Interferon β in multiple sclerosis", Clin. Immunol. Immunopathol. 81, 1-11.
29. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.H. and Tourtellotte, W.W. (1983) "New diagnostic criteria for multiple sclerosis: Guidelines for research protocols", Ann. Neurol. 13, 227-231.
30. Kurtzke, J.F. (1983) "Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)", Neurology 33, 1444-1452.
31. Zettl, U.K., Mix, E., Gold, R., Rothe, G. and Hartung, H.-P. (1996) "Detection of oxidative burst and apoptotic cell death in cerebrospinal fluid (CSF) and blood", J. Lab. Med. 20, 176-177.
32. Gold, R., Schmied, M., Giegerich, G., Breitschopf, H., Hartung, H.-P., Toyka, K.V. and Lassmann, H. (1994) "Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques", Lab. Investig. 71, 219-225.
33. Taniguchi, T. and Takaoka, A. (2001) "A weak signal for strong responses: Interferon-α/β revisited", Nat. Rev. Mol. Biol. 2, 378-386.
34. Martin, R., Stürzebecher, C.S. and McFarland, H.F. (2001) "Immunotherapy of multiple sclerosis: Where are we? Where should we go?", Nat. Immunol. 2, 785-788.
35. Zipp, F., Beyer, M., Gelderblom, H., Wernet, D., Zschenderlein, R. and Weller, M. (2000) "No induction of apoptosis by IFN-β in human antigen-specific T cells", Neurology 54, 485-487.
36. Lucas, M., Sánchez-Solińo, O., Solano, F. and Izquíerdo, G. (1998) "Interferon β-1b inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis", Neurochem. Int. 33, 101-102.
37. Lucchinetti, C., Bruck, W. and Noseworthy, J. (2001) "Multiple sclerosis: Recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment", Curr. Opin. Neurol. 14, 259-269.
38. Perry, V.H. (1998) "A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation", J. Neuroimmunol. 90, 113-121.
39. Hartung, H.P., Hughes, R.A., Taylor, W.A., Heininger, K., Reiners, K. and Toyka, K.V. (1990) "T cell activation in Guillain-Barre syndrome and in MS: Elevated serum levels of soluble IL-2 receptors", Neurology 40, 215-218.
40. 4 T-lymphocytes in relapsing-remitting multiple sclerosis patients: A serial analysis", J. Neuroimmunol. 66, 147-151.
41. Mirowska, D., Páz, A., Zaborski, J., Korlak, J., Koronkiewicz, M., Skierski, J., Członkowski, A. and Członkowska, A. (2001) "Changes in the immunological profile of peripheral blood leukocytes in multiple sclerosis (MS) patients treated with interferon-β-1a", J. Lab. Med. 25, 157-160.
42. Byskosh, P.V. and Reder, A.T. (1996) "Interferon β-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis", Mult. Scler. 1, 262-269.
43. Rudick, R.A., Ransohoff, RM., Peppler, R., VanderBrug Medendorp, S., Lehmann, P. and Alam, J. (1996) "Interferon-β induces interleukin-10 expression: Relevance to multiple sclerosis", Ann. Neurol. 40, 618-627.
44. Byrnes, A.A., McArthur, J.C. and Karp, C.L. (2002) "Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production", Ann. Neurol. 51, 165-174.
45. Andersson, M., Khademi, M., Wallström, E. and Olssson, T. (1997) "Cytokine profile in interferon-β treated multiple sclerosis patients: Reduction of interleukin-10 mRNA expressing cells in peripheral blood", Eur. J. Neurol. 4, 567-571.
46. Waubant, E., Gee, L., Bacchetti, P., Sloan, R., Cotleur, A., Rudick, R. and Goodkin, D. (2001) "Relationship between serum levels of IL-10, MRI activity and interferon β-1a therapy in patients with relapsing remitting MS", J. Neuroimmunol. 112, 139-145.
47. Rothuizen, L.E., Buclin, T., Spertini, F., Trinchard, I., Munafo, A., Buchwalder, P.-A., Ythier, A. and Biollaz, J. (1999) "Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers", J. Neuroimmunol. 99, 131-141.
48. Ossege, L.M., Sindern, E., Patzold, T. and Malin, J.-P. (1998) "Immunomodulatory effects of interferon-β-1b in vivo: Induction of the expression of transforming growth factor-β1 and its receptor type II", J. Neuroimmunol. 91, 73-81.
49. Lünemann, J.D., Aktas, O., Gniadek, P., Zschenderlein, R. and Zipp, F. (2001) "Downregulation of transforming growth factor-β1a (TGF-β1a) treated multiple sclerosis (MS) patients (Abstract)", J. Neurol. 248 (Suppl. 2), 135.
50. Becher, B., Giacomini, P.S., Pelletier, D., McCrea, E., Prat, A. and Antel, J.P. (1999) "Interferon-γ secretion by peripheral blood T-cell subsets in multiple sclerosis: Correlation with disease phase and interferon-β therapy", Ann. Neurol. 45, 247-250.
51. Furlan, R., Bergami, A., Lang, R., Brambilla, E., Franciotta, D., Martinelli, V., Comi, G., Panina, P. and Martino, G. (2000) "Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4", J. Neuroimmunol. 111, 86-92.
52. Limone, P., Ferrero, B., Calvelli, P., Del Rizzo, P., Rota, E., Berardi, C., Barberis, A.M., Isaia, G.C. and Durelli, L. (2002) "Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with and without interferon-β treatment", Acta Neurol. Scand. 105, 372-377.
53. Pacocha, S.E., Oriente, A., Lichtenstein, L.M., Huang, S.K. and Essayan, D.M. (2000) "Interferon-β induces selective enhancement of antigen-specific T cell responses", J. Interferon Cytokine Res. 20, 383-389.
54. Qu, Z.X., Pliskin, N., Jensen, M.W., White, D. and Arnason, B.G. (2001) "Etretinate augments interferon β-1b effects on suppressor cells in multiple sclerosis", Anat. Neurol. 58, 87-90.
55. Ekerfelt, C., Ernerudh, J., Solders, G. and Vrethem, M. (1995) "CD5 expression on B cells may be an activation marker for secretion of anti-myelin antibodies in patients with polyneuropathy associated with monoclonal gammapathy", Clin. Exp. Immunol. 101, 346-350.
56. De Libero, G. (2000) "Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases", Springer Semin. Immunopathol. 22, 219-238.
57. Shimonkevitz, R., Colburn, C., Burnham, J.A., Murray, R.S. and Kotzin, B.L. (1993) "Clonal expansion of activated γδ T cells in recent-onset multiple sclerosis", Proc. Natl Acad. Sci. USA 90, 923-927.
58. Mix, E. and Meyer-Rienecker, H. (1996) "Fetal-type lymphocytes in blood and cerebrospinal fluid (CSF) in inflammatory diseases of the central nervous system (CNS)", J. Lab. Med. 20, 166-167.
59. Rodriguez, M., Miller, D.J. and Lennon, V.A. (1996) "Immunoglobulins reactive with myelin basic protein promote CNS remyelination", Neurology 46, 538-545.
60. Zipp, F., Weller, M., Calabresi, P.A., Frank, J.A., Bash, C.N., Dichgans, J., McFarland, H.F. and Martin, R. (1998) "Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis", Ann. Neurol. 43, 116-120.
61. White, C.A., Nguyen, K.B. and Pender, M.P. (2000) "B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: Roles of B cell CD95, CD95L and Bcl-2 expression", J. Autoimmun. 14, 195-204.
62. Mix, E., Zettl, U.K., Zielasek, J., Hartung, H.-P. and Gold, R. (1999) "Apoptosis induction by macrophage-derived reactive oxygen species in myelin-specific T cells requires cell-cell contact", J. Neuroimmunol. 95, 152-156.
63. Leussink, V.I., Jung, S., Merschdorf, U., Toyka, K.V. and Gold, R. (2001) "High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes", Arch. Neurol. 58, 91-97.